Karen Smith, MD, PhD, MBA, LLM, joins with over 25 years of global pharma and biotech experience, having contributed to more than 20 regulatory ...
The benchmark indices will likely remain range-bound and consolidative, with a focus on quarterly earnings, management commentaries for the second half of FY26, further developments related to ...
EMA concludes that the primary endpoint and supportive secondary endpoints from prior successful Phase 3 studies conducted in ...
Expands commercial readiness and diagnostic, manufacturing footprintAppoints new leadership in commercial strategy and technical ...
Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing cell and gene therapies for ...
NRG Therapeutics made three senior appointments in newly created roles: Sarah Almond as VP of translational biology; David Brocklebank as director of clinical operations and Kathryn Oliver as director ...
During the process, the management consulting offered 46% of all offers followed by investment banking and product management ...
There is no evidence that less frequent financial reporting impairs company performance, market functioning, or the quality of investor information.
October was a magnificent month for Bloom Energy stock. October was a significant month for Bloom Energy on several big counts, and there were three massive catalysts th ...
IIM Calcutta Secures 100 Pc Summer Placements For 62Nd MBA Batch. Kolkata, Oct 27 (IANS) The Indian Institute of Management ...
Over the past two decades, I’ve observed significant shifts in the life sciences, pharmaceutical, and CDMO landscape. Pharmaceutical companies and their outsourcing partners must continuously adapt to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback